stylize image of Boston, MA; DIA 2023 concept

DIA 2023 Global Annual Meeting: Can’t-Miss Sessions

If you work within the life science industry, mark your calendar for June 25-29 and plan to attend the DIA 2023 Global Annual Meeting in Boston, Massachusetts.

The Drug Information Association conference brings together more than 5,000 attendees from all parts of the life sciences field, including academics, government regulators, thought leaders, and even patients. It aims to highlight different perspectives across the life sciences field to help professionals develop a 3D view of everyone involved.

There are countless reasons to attend this conference, from the 500 unique speakers and 170 sessions to the unique exhibitors presenting in the main hall. Here are a few of our can’t-miss highlights that we think you should put on your calendar.

Revolutionizing Life Sciences: How Diversity, Innovation, and AI are Accelerating the Future of Health

Monday, June 26 at 9 a.m.
Junaid Bajwa is the Chief Medical Scientist at Microsoft Research and a practicing physician for the National Health Service in the UK. He is also the keynote speaker for this conference. If you attend only one session at DIA 2023, make sure it is this one.

The keynote address will feature a panel discussion in what promises to be an engaging and interactive session. Led by Bajwa, the audience will bring the audience into the conversation to share their perspectives. Not only will this be a riveting discussion about DEI in clinical trials and research, but it will also focus on the role of AI in these efforts.

Inspired by Big-Tech and Humbled by Complexity of Clinical Research: Clinical Trial Digital Transformation

Monday, June 26 at 10:45 a.m.
Nareen Katta, head of Data Science and Analytics at AbbVie, will be sharing his experience with a multi-year clinical trial digital transformation initiative. The presentation will start at the beginning (considerations prior to embarking on a major digital transformation initiative) and then will walk through his experiences and roadblocks that occurred along the way.

This is an intermediate-level session that is part of the Data Tech track.

speaker in front of crowded room; DIA 2023 concept

Blockchain-Based Technologies for Clinical Research: Distinguishing Myth from Reality

Monday, June 26 at 12:00 p.m.
Hadil Es-Sbai, cofounder and CEO of CR2O, will be leading this Q&A workshop that busts the myths of what blockchain is actually capable of. Because this technology is new, there is a lot of misunderstanding and misinformation surrounding it. Es-Sbai will highlight the common myths around blockchain and counter them with real-world examples of what this technology can do.

This is an intermediate-level session that is part of both the Data Tech and Content Hubs tracks.

Meta-Collaboration to Improve Decentralized Trial Excellence: Updates from the Collaboration Landscape

Tuesday, June 27 at 1:15 p.m.
Craig Lipset is the co-chair of the Decentralized Trials and Research Alliance (DTRA) in the United States. This session will highlight the efforts to develop and implement DCTs and the risks that come with too many differentiated trials. Lipset will discuss best practices for ensuring different trials fit together and maintaining data integrity throughout.

This is an intermediate-level session that is part of the ClinTrials and ClinOps track.

Patients’ Engagement in Drug Development and in Public Private Partnerships

Tuesday, June 27 at 2:30 p.m.
Solange Corriol-Rohou, senior director of Global Regulatory Affairs & Policy at AstraZeneca, will lead this workshop on patient experience data. She will discuss the collection of anecdotal data from the early development processes all the way through the production of the final product. Corriol-Rohou will also address using patient stories in the regulatory process. It will be a great workshop for learning how to balance concrete data with patient stories and feedback.

This is an intermediate-level session that is part of the Content Hubs and Patient Engagement tracks.

Real-World Data: Maximizing Value and Quality Through End-to-End Patient Centricity

Wednesday, June 28 at 1:15 p.m.
Meghan Tierney, senior clinical scientist at PicnicHealth, wants to better connect patients to real-world data. Patients often don’t know what data points are important, which means they might not be as diligent in collecting the data or recording it accurately. That can lead to poor data in clinical trials. Through end-to-end patient centricity, all parties involved in the trial will benefit.

This is a basic-level session that is part of the ClinTrials-ClinOps, Data-Tech, Patient Engagement, and Value-Access tracks.

Don’t Forget to Visit Anju in the Exhibit Hall

DIA is one of the leading conferences in the life sciences field. It’s easy to get overwhelmed by the sheer number of tracks and presentations available.

While you’re at the conference, don’t forget to stop by our booth (#307) in the exhibition hall. Our team will be happy to talk about how we reduce complexities in drug and device discovery while improving patient experiences. We can’t wait to see you there.

Images used under license from

Want to stay up to date with our news?

To top